The official journal of ASTRO.

Related StoriesInvestment in radiotherapy services could save lives, increase economy in developing countriesUM SOM researchers to initiate first scientific trial of GammaPod system in patients with early-stage breast cancerLilly, ImaginAb partner to review potential novel T-cell-centered immuno-oncology therapiesThe IGRT guidelines address the clinical execution of IGRT, including personnel qualifications, quality assurance requirements and recommended documentation. SBRT is normally a type of exterior beam radiation therapy that can be completed in a single to five days rather than several weeks and is most commonly used for small tumors. This is a newer form of treatment that is rapidly evolving and requires degrees of precision and accuracy that surpass the requirements of regular fractionated radiation therapy or intensity-modulated delivery.All rights reserved.. AcelRx completes private placement of common stock AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical firm focused on the advancement and commercialization of innovative therapies for the treating acute and breakthrough discomfort, announced today that it finished its previously announced private placement of common stock and warrants to get common share on June 1, 2012.0 million. Related StoriesCombatting viral and bacterial lung attacks with volatile anesthetics: an interview with Dr ChakravarthyBRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical SchoolScripps Florida researchers win $2.4 million to expand advancement of new pain issued an aggregate of 2 therapiesAcelRx,922,337 newly-issued shares of common share and warrants to purchase up to 2,630,103 additional shares of common stock.

D, with the name of ‘Fellow’ in reputation of the excellence she has attained in pharmacy practice.